Healthcare -
Biotechnology - NYSE - US
$ 8.475
2.85 %
$ 487 M
Market Cap
-0.8
P/E
DNA - CASH FROM OPERATIONS
Cash from Operations DNA - Ginkgo Bioworks Holdings, Inc.
-296 M
LAST VALUE
-7.90%
2 YEAR CAGR
-15.16%
5 YEAR CAGR
0.00%
10 YEAR CAGR